文献

J-GLOBAL ID：202202276434868563   整理番号：22A0705638

体外膜型人工肺(ASAP ECMO研究)を受けた重症成人患者におけるバンコマイシンの母集団薬物動態【JST・京大機械翻訳】

Population Pharmacokinetics of Vancomycin in Critically Ill Adult Patients Receiving Extracorporeal Membrane Oxygenation (an ASAP ECMO Study)

著者 (37件)： Cheng Vesa (University of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia) ,  Cheng Vesa (Adult Intensive Care Services and Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia) ,  Abdul-Aziz Mohd H. (University of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia) ,  Burrows Fay (Department of Pharmacy, St Vincent’s Hospital, Sydney, New South Wales, Australia) ,  Buscher Hergen (Department of Intensive Care Medicine, St Vincent’s Hospital, Sydney, New South Wales, Australia) ,  Buscher Hergen (St Vincent’s Centre for Applied Medical Research, University of New South Wales, Sydney, New South Wales, Australia) ,  Cho Young-Jae (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea) ,  Corley Amanda (Adult Intensive Care Services, the Prince Charles Hospital, Chermside, Australia) ,  Diehl Arne (Department of Intensive Care and Hyperbaric Medicine, The Alfred Hospital, Melbourne, Victoria, Australia) ,  Diehl Arne (School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia) ,  Gilder Eileen (Cardiothoracic and Vascular Intensive Care Unit, Auckland City Hospital, Auckland, New Zealand) ,  Jakob Stephan M. (Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland) ,  Kim Hyung-Sook (Department of Pharmacy, Seoul National University Bundang Hospital, Seongnam, Republic of Korea) ,  Levkovich Bianca J. (Experiential Development and Graduate Education and Centre for Medicines Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia) ,  Lim Sung Yoon (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea) ,  McGuinness Shay (Cardiothoracic and Vascular Intensive Care Unit, Auckland City Hospital, Auckland, New Zealand) ,  Parke Rachael (Cardiothoracic and Vascular Intensive Care Unit, Auckland City Hospital, Auckland, New Zealand) ,  Parke Rachael (School of Nursing, The University of Auckland, Auckland, New Zealand) ,  Pellegrino Vincent (Department of Intensive Care and Hyperbaric Medicine, The Alfred Hospital, Melbourne, Victoria, Australia) ,  Pellegrino Vincent (School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia) ,  Que Yok-Ai (Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland) ,  Reynolds Claire (Department of Intensive Care Medicine, St Vincent’s Hospital, Sydney, New South Wales, Australia) ,  Rudham Sam (Department of Intensive Care Medicine, St Vincent’s Hospital, Sydney, New South Wales, Australia) ,  Wallis Steven C. (University of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia) ,  Welch Susan A. (Department of Pharmacy, St Vincent’s Hospital, Sydney, New South Wales, Australia) ,  Zacharias David (Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland) ,  Fraser John F. (Adult Intensive Care Services and Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia) ,  Fraser John F. (Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia) ,  Fraser John F. (Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia) ,  Fraser John F. (Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Queensland, Australia) ,  Shekar Kiran (Adult Intensive Care Services and Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia) ,  Shekar Kiran (Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia) ,  Shekar Kiran (Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia) ,  Shekar Kiran (Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Queensland, Australia) ,  Roberts Jason A. (University of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia) ,  Roberts Jason A. (Departments of Intensive Care Medicine and Pharmacy, Royal Brisbane and Women’s Hospital, Brisbane, Queensland, Australia) ,  Roberts Jason A. (Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nimes University Hospital, University of Montpellier, Nimes, France)
資料名： Antimicrobial Agents and Chemotherapy  (Antimicrobial Agents and Chemotherapy)
巻： 66  号： 1  ページ： Null  発行年： 2022年 
JST資料番号： E0802A  ISSN： 0066-4804  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： アメリカ合衆国 (USA)  言語： 英語 (EN)

抄録/ポイント： 本研究は,同時腎置換療法(RRT)を受けている患者を含む体外膜酸素化(ECMO)を受けている重症患者におけるバンコマイシンの集団薬物動態(PK)を記述することを目的とした。ドースシミュレーションを用いて,最大有効かつ安全な投与レジメンを推薦した。Please refer to the publisher for the copyright holders. Translated from English into Japanese by JST.【JST・京大機械翻訳】

シソーラス用語： 成人 ,  *薬物動力学 ,  *患者 ,  *母集団 ,  *人工肺 ,  投与計画 ,  アミノ糖 ,  シクロペプチド ,  芳香族塩素化合物 ,  オリゴペプチド ,  多価フェノール ,  二糖類 ,  架橋化合物 ,  ピラノシド ,  芳香族縮合化合物
準シソーラス用語： 膜型人工肺 ,  腎機能代替療法 ,  重症患者 ,  *外膜 , 【Automatic Indexing@JST】

分類 (2件)： 生物薬剤学(臨床)  (GY01022L) ,  感染症・寄生虫症の治療  (GD01030D)

物質索引 (1件)： バンコマイシン

タイトルに関連する用語 (8件)： 膜型人工肺 ,  ECMO ,  研究 ,  重症 ,  成人 ,  患者 ,  バンコマイシン ,  母集団薬物動態